The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Mesenchymal Stem Cell: Keystone of the Hematopoietic Stem Cell Niche and a Stepping-Stone for Regenerative Medicine
Open accessAbstract
Mesenchymal stem cells (MSCs) are self-renewing precursor cells that can differentiate into bone, fat, cartilage, and stromal cells of the bone marrow. Recent studies suggest that MSCs themselves are critical for forming a niche that maintains hematopoietic stem cells (HSCs). The ease by which human MSC-like and stromal progenitor cells can be isolated from the bone marrow and other tissues has led to the rapid development of clinical investigations exploring their anti-inflammatory properties, tissue preservation capabilities, and regenerative potential. However, the identity of genuine MSCs and their specific contributions to these various beneficial effects have remained enigmatic. In this article, we examine the definition of MSCs and discuss the importance of rigorously characterizing their stem cell activity. We review their role and that of other putative niche constituents in the regulation of bone marrow HSCs. Additionally, how MSCs and their stromal progeny alter immune function is discussed, as well as potential therapeutic implications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, reprogrammed immune cells can use the immune system to treat cancer and administer vaccinations, while microorganisms can interact with the microbiome to control metabolic processes, chronic inflammatory processes, and mucosal immunity.320–322”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [322]
In the citing paper
“For instance, reprogrammed immune cells can use the immune system to treat cancer and administer vaccinations, while microorganisms can interact with the microbiome to control metabolic processes, chronic inflammatory processes, and mucosal immunity.320–322”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [322]
Citations
Cites
1 retracted
Items 201–236 of 236
Stockmann, P., Park, J. H., von Wilmowsky, C., Nkenke, E., Felszeghy, E., Dehner, J.-F., Schmitt, C., Tudor, C., & Schlegel, K. A. (2011) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2011.05.004 · Cited by 125
Bhattacharya, D., Rossi, D. J., Bryder, D., & Weissman, I. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051714 · Cited by 124
Inhibition of PPARγ prevents type I diabetic bone marrow adiposity but not bone loss
Boțolin, S., & McCabe, L. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20804 · Cited by 118
Bone Regeneration in a Rabbit Critical-Sized Skull Defect Using Autologous Adipose-Derived Cells
Bella, C. D., Farlie, P. G., & Penington, A. (2008) · Tissue Engineering Part A · doi:10.1089/tea.2007.0137 · Cited by 117
Human vascular adventitial fibroblasts contain mesenchymal stem/progenitor cells
Hoshino, A., Chiba, H., Nagai, K., Ishii, G., & Ochiai, A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.090 · Cited by 109
Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells
Yao, L., Yokota, T., Xia, L., Kincade, P. W., & McEver, R. P. (2005) · Blood · doi:10.1182/blood-2005-02-0671 · Cited by 106
Gieseke, F., Schüett, B. S., Viebahn, S., Kościelniak, E., Friedrich, W., Handgretinger, R., & Müller, I. (2007) · Blood · doi:10.1182/blood-2007-04-083162 · Cited by 104
Sbano, P., Cuccia, A., Mazzanti, B., Urbani, S., Giusti, B., Lapini, I., Rossi, L., Abbate, R., Marseglia, G., Nannetti, G., et al. (2008) · Archives of Dermatological Research · doi:10.1007/s00403-007-0827-9 · Cited by 99
Receptor Tyrosine Kinase Axl Modulates the Osteogenic Differentiation of Pericytes
Collett, G. D. M., Wood, A. C., Alexander, M. Y., Varnum, B. C., Boot-Handford, R., Ohanian, V., Ohanian, J., Fridell, Y.-W. C., & Canfield, A. E. (2003) · Circulation Research · doi:10.1161/01.res.0000074881.56564.46 · Cited by 93
Chute, J. P., Muramoto, G. G., Salter, A. B., Meadows, S. K., Rickman, D. W., Chen, B., Himburg, H. A., & Chao, N. J. A. (2006) · Blood · doi:10.1182/blood-2006-05-022640 · Cited by 92
Gottschling, S., Saffrich, R., Seckinger, A., Krause, U., Horsch, K., Miesala, K., & Ho, A. D. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0513 · Cited by 82
Harrison, D. E., & Zhong, R. K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10134 · Cited by 80
Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells
Ravi, R. K., McMahon, M., Yangang, Z., Williams, J. R., Dillehay, L. E., Nelkin, B. D., & Mabry, M. H. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990315)72:4 · Cited by 75
Bae, S., Ahn, J. H., Park, C. W., Son, H. K., Kim, K., Lim, N., Jeon, C., & Kim, H. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0729-y · Cited by 68
Chondrogenesis by chemotactic homing of synovium, bone marrow, and adipose stem cells in vitro
Mendelson, A., Frank, E., Allred, C., Jones, E., Chen, M., Zhao, W., & Mao, J. J. (2011) · The FASEB Journal · doi:10.1096/fj.10-176305 · Cited by 68
Dittmer, A., Hohlfeld, K., Lützkendorf, J., Müller, L. P., & Dittmer, J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0089-0 · Cited by 67
Back to the future: Moving beyond “mesenchymal stem cells”
Bianco, P. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23103 · Cited by 66
Khoury, M., Drake, A. C. B., Chen, Q., Dong, D., Leskov, I. B., Fragoso, M. F., Li, Y., Iliopoulou, B. P., Hwang, W. Y. K., Lodish, H. F., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0456 · Cited by 64
Jääger, K., Islam, S., Zając, P., Linnarsson, S., & Neuman, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038833 · Cited by 64
Multi-lineage expansion potential of primitive hematopoietic progenitors
Lewis, I. D., & Verfaillie, C. M. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00515-4 · Cited by 63
Hidalgo, A., & Frenette, P. S. (2004) · Blood · doi:10.1182/blood-2004-03-1026 · Cited by 54
Self-citationLin, S., Yang, J. T., Everett, A. D., Clevenger, C. V., Koneru, M., Mishra, P. K., Kamen, B. A., BANERJEE, D., & Glod, J. W. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.07.028 · Cited by 54
Purification and Culture of Human Blood Vessel–Associated Progenitor Cells
Crisan, M., Huard, J., Zheng, B. J., Sun, B., Yap, S. V., Logar, A., Giacobino, J., Casteilla, L., & Péault, B. (2008) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc02b02s4 · Cited by 53
Suire, C., Brouard, N., Hirschi, K. K., & Simmons, P. J. (2012) · Blood · doi:10.1182/blood-2011-08-372334 · Cited by 47
Lévesque, J.-P., Hendy, J., Takamatsu, Y., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200315994 · Cited by 46
The secrets of the bone marrow niche: Enigmatic niche brings challenge for HSC expansion
Kunisaki, Y., & Frenette, P. S. (2012) · Nature Medicine · doi:10.1038/nm.2825 · Cited by 40
Self-citationXu, G., Zhang, Y., Zhang, L., Roberts, A. I., & Shi, Y. (2009) · Stem Cells · doi:10.1002/stem.22 · Cited by 38
Fei, X. M., Wu, Y., Chang, Z., Miao, K., Tang, Y.-H., Zhou, X. Y., Wang, L. X., Pan, Q. Q., & Wang, C. (2007) · Cytotherapy · doi:10.1080/14653240701291638 · Cited by 38
Flores-Guzmán, P., Figueroa, E. F., Montesinos, J. J., Martínez‐Jaramillo, G., Fernández-Sánchez, V., Valencia‐Plata, I., Alarcón-Santos, G., & Mayani, H. (2009) · Cytotherapy · doi:10.3109/14653240903180076 · Cited by 36
No stimulative effect of adipocytes on hematopoiesis in long-term human bone marrow cultures
Touw, I. P., & Lowenberg, B. (1983) · Blood · doi:10.1182/blood.v61.4.770.770 · Cited by 31
Kitano, Y., Radu, A., Shaaban, A. F., & Flake, A. W. (2000) · Experimental Hematology · doi:10.1016/s0301-472x(00)00551-8 · Cited by 31
Insights into the biology of cord blood stem/progenitor cells
Broxmeyer, H. E. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2010.00728.x · Cited by 28
Broxmeyer, H. E., Srour, E. F., Cooper, S. H., Wallace, C. T., Hangoc, G., & Youn, B. (2011) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2011.09.004 · Cited by 24
Yan, S., Krebs, S. J., Leister, K. J., & Wenner, C. E. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200010)185:1 · Cited by 11
Texas prepares to fight for stem cells
Cyranoski, D. (2011) · Nature · doi:10.1038/477377a · Cited by 10
Collins (1998) · doi:10.1002/(sici)1097-4652(199807)176:1
Research works printed but not linked: 10
- Friedenstein AJ, 1976, Exp. Hematol., 4, 267
- Friedenstein AJ, 1982, Exp. Hematol., 10, 217
- Dexter TM, 1977, Biomedicine, 27, 344
- Maltman DJ, 2011, Neurochem. Int., 59, 347
- in ‘t Anker PS, 2003, Haematologica, 88, 845
- Owen M, 1988, Ciba Found. Symp., 136, 42
- 10.1016/0008-6363(96)00063-6 · DOI
- Schofield R, 1978, Blood Cells, 4, 7
- Studeny M, 2002, Cancer Res., 62, 3603
- Cyranoski D, 2011, Nature, 477, 377
Cited by
Sorted by citations
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
Arteriolar niches maintain haematopoietic stem cell quiescence
Kunisaki, Y., Bruns, I., Scheiermann, C., Ahmed, J. U., Pinho, S., Zhang, D., Mizoguchi, T., Wei, Q., Lucas, D., Ito, K., et al. (2013) · Nature · doi:10.1038/nature12612 · Cited by 1,290
“The association and quiescence of both haematopoietic and mesenchymal stem cells at this site may thus endow arterioles with the potential for orchestrating haematopoietic and stromal regeneration 40 .”
Self-citationSmart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073
“322 Additionally, living cells are modi fi able.”
BackgroundHaematopoietic stem cell activity and interactions with the niche
Pinho, S., & Frenette, P. S. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0103-9 · Cited by 1,064
Self-citation
Metadata
- Authors
- Frenette, P. S., Pinho, S., Lucas, D., & Scheiermann, C.
- Affiliations
- Albert Einstein College of Medicine (US)
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2013-03-21
- Volume
- 31
- Issue
- 1
- Pages
- 285-316
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2138953281
- Cited by
- 462
- References
- 235
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 27 · 2023: 27 · 2022: 23 · 2021: 39 · 2020: 35 · 2019: 34 · 2018: 41 · 2017: 42 · 2016: 38 · 2015: 51 · 2014: 54 · 2013: 27
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (R01HL116340, R01HL097700, R01HL069438, R01HL097819)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056638)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Keywords
- mesenchymal stem cells, hematopoietic stem cells, bone marrow microenvironment, stromal progenitor cells, immune function, anti-inflammatory activity, regenerative medicine, stem cell therapy
- MeSH terms
- Animals, Bone Marrow Cells, Humans, Inflammation, Stem Cells, Stromal Cells, Hematopoietic Stem Cell Transplantation, Regenerative Medicine, Mesenchymal Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
